Yaping Tu, PhD

Yaping Tu, PhD

Executive Director, Head of Clinical Pharmacology @ ImmunoGen, Inc.

About

• Proven track record in clinical pharmacology with BLA and MAA approvals • Substantial expertise in population PK and PK/PD modeling and simulation • Extensive experience in drug metabolism and pharmacokinetics • Hands-on experience in clinical study design and data analysis • Familiar with small molecules, fusion proteins, and antibody-drug conjugates • Experience in oncology, neurology, immunotherapy, and infectious diseases

Country

United States

City

Raleigh-Durham-Chapel Hill Area

Industry

Pharmaceuticals

Skill

Clinical Pharmacology, BLA and MAA filing, Drug Discovery, DMPK, Drug Metabolism, LC-MS, Mass Spectrometry, Pharmacokinetics, ADME, In Vitro, Chromatography, Organic Chemistry, Clinical Development, Analytical Chemistry, HPLC, GLP, Drug Development, Bioanalysis, Infectious Diseases

Experience

ImmunoGen, Inc.

Executive Director, Head of Clinical Pharmacology

ImmunoGen, Inc.

LinkedIn
2021-6 - Present · 5 yrs 4 mos

Waltham, Massachusetts

* BLA and MAA - from filing to approval * Population PK and exposure-response analysis * Pivotal and early phase clinical trials * Oncology - Solid tumors and hematology * Antibody-drug conjugates

PTC Therapeutics, Inc.

Director, Clinical Pharmacology

PTC Therapeutics, Inc.

LinkedIn
2018-8 - 2021-6 · 2 yrs 11 mos

South Plainfield, New Jersey

* Clinical pharmacokinetics * Population PK and PK/PD modeling and simulation * Oncology - Solid tumors and hematological malignancy * Neurology - Huntington's disease

Mirata Biopharma

Director, DMPK and Clinical Pharmacology

Mirata Biopharma

2017-3 - 2018-8 · 1 yr 6 mos

Houston, Texas

* Clinical pharmacokinetics * Nonclinical PK/PD and safety * Oncology - Solid tumors and hematology * Targeted cancer therapies - Fusion proteins

GSK

Senior Chief Scientist, DMPK

GSK

LinkedIn
2009-2 - 2017-3 · 8 yrs 2 mos

Research Triangle Park, North Carolina

* PK/PD modeling and simulation * Early phase clinical study design * Nonclinical PK/PD studies * Infectious diseases; Immunotherapy; Inflammatory; Inhalation; Nanoparticles.

Genelabs Technologies

Associate Director, DMPK

Genelabs Technologies

LinkedIn
2007-8 - 2009-2 · 1 yr 7 mos

Redwood City, California

* Nonclinical ADME/PK * Metabolite identification and profiling * Reactive metabolite and drug safety * Infectious diseases

Roche

Research Scientist, DMPK

Roche

LinkedIn
2002-7 - 2007-8 · 5 yrs 2 mos

Palo Alto, California

* Clinical PK and bioanalysis * Nonclinical PK * Metabolite identification and profiling * Infectious and inflammatory diseases

Education

University of Toronto

University of Toronto

LinkedIn

Chemistry

University of Ottawa

University of Ottawa

LinkedIn

Chemistry

Yaping Tu, PhD's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.